Cell-free DNA Analysis for Noninvasive Examination of Trisomy
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cell-free DNA (cfDNA) testing for fetal trisomy is highly effective among high-risk women. However, there have been few direct, well-powered studies comparing cfDNA testing with standard screening during the first trimester in routine prenatal populations. METHODS: In this prospective, multicenter, blinded study conducted at 35 international centers, we assigned pregnant women presenting for aneuploidy screening at 10 to 14 weeks of gestation to undergo both standard screening (with measurement of nuchal translucency and biochemical analytes) and cfDNA testing. Participants received the results of standard screening; the results of cfDNA testing were blinded. Determination of the birth outcome was based on diagnostic genetic testing or newborn examination. The primary outcome was the area under the receiver-operating-characteristic curve (AUC) for trisomy 21 (Down's syndrome) with cfDNA testing versus standard screening. We also evaluated cfDNA testing and standard screening to assess the risk of trisomies 18 and 13. RESULTS: Of 18,955 women who were enrolled, results from 15,841 were available for analysis. The mean maternal age was 30.7 years, and the mean gestational age at testing was 12.5 weeks. The AUC for trisomy 21 was 0.999 for cfDNA testing and 0.958 for standard screening (P=0.001). Trisomy 21 was detected in 38 of 38 women (100%; 95% confidence interval [CI], 90.7 to 100) in the cfDNA-testing group, as compared with 30 of 38 women (78.9%; 95% CI, 62.7 to 90.4) in the standard-screening group (P=0.008). False positive rates were 0.06% (95% CI, 0.03 to 0.11) in the cfDNA group and 5.4% (95% CI, 5.1 to 5.8) in the standard-screening group (P<0.001). The positive predictive value for cfDNA testing was 80.9% (95% CI, 66.7 to 90.9), as compared with 3.4% (95% CI, 2.3 to 4.8) for standard screening (P<0.001). CONCLUSIONS: In this large, routine prenatal-screening population, cfDNA testing for trisomy 21 had higher sensitivity, a lower false positive rate, and higher positive predictive value than did standard screening with the measurement of nuchal translucency and biochemical analytes. (Funded by Ariosa Diagnostics and Perinatal Quality Foundation; NEXT ClinicalTrials.gov number, NCT01511458.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, cfDNA analysis has been useful for non-invasive prenatal testing applications, such as for the identification of trisomy 21 (ref.124).”
From Clinical metagenomics (2019) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
Malone, F. D., Canick, J. A., Ball, R. H., Nyberg, D. A., Comstock, C. H., Bukowski, R., Berkowitz, R. L., Gross, S. J., Dugoff, L., Craigo, S. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043693 · Cited by 1,081
Palomaki, G. E., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Neveux, L. M., Ehrich, M., van den Boom, D., Bombard, A. T., Deciu, C., Grody, W. W., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182368a0e · Cited by 939
Gil, M. M., Quezada, M. S., Revello, R., Akolekar, R., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14791 · Cited by 807
Akolekar, R., Beta, J., Picciarelli, G., Ogilvie, C., & D'Antonio, F. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14636 · Cited by 711
Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population
Nicolaides, K. H., Syngelaki, A., Ashoor, G., Birdir, C., & Touzet, G. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.08.033 · Cited by 624
DNA Sequencing versus Standard Prenatal Aneuploidy Screening
Bianchi, D. W., Parker, R. L., Wentworth, J., Madankumar, R., Saffer, C., Das, A. F., Craig, J. A., Chudova, D. I., Devers, P. L., Jones, K. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311037 · Cited by 620
Norton, M. E., Brar, H., Weiss, J., Karimi, A., Laurent, L. C., Caughey, A. B., Rodriguez, M. H., Williams, J., Mitchell, M. E., Adair, C. D., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.05.021 · Cited by 596
Self-citationFirst-Trimester Screening for Trisomies 21 and 18
Wapner, R., Thom, E., Simpson, J. L., Pergament, E., Silver, R., Filkins, K., Platt, L., Mahoney, M., Johnson, A., Hogge, W. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025273 · Cited by 563
Self-citationDNA Sequencing Versus Standard Prenatal Aneuploidy Screening
Rochon, M. L. (2014) · Cited by 468
Cited by
Items 601–700 of 817
Miny, P., Filges, I., Tercanli, S., & Holzgreve, W. (2018) · Wiley eBooks · doi:10.1002/9780470015902.a0027053 · Cited by 2
Maternal blood test is more effective than standard screening for Down's syndrome, study shows
Mayor, S. (2015) · BMJ · doi:10.1136/bmj.h1797 · Cited by 1
Retrospective results of our Non-Invasive Prenatal Test (NIPT) experience
Atlıhan, U., Bıldacı, T. B., Erkılınç, S., Yavuz, O., Avşar, H. A., & Ata, C. (2024) · Ege Tıp Dergisi · doi:10.19161/etd.1496635 · Cited by 1
Nakamura, T., 白土, な., Ishii, T., Koide, K., Miyagami, K., Yamada, T., & Sekizawa, A. (2025) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16324 · Cited by 1
Shekhawat, D. S., Kulkarni, U., Sharma, C., Singh, P., & Singh, K. (2025) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_836_24 · Cited by 1
Perinatal outcomes of resolved fetal cystic hygromas
Peek, E., Collins, L. C., Santoli, C. M. A., Sparks, T. N., Kuller, J. A., & Dotters-Katz, S. K. (2025) · Pregnancy · doi:10.1002/pmf2.70054 · Cited by 1
Lee, S.-Y., Koo, S., Kim, S. W., Kim, M., Lee, E. H., Lee, S. G., & Han, S. (2025) · Laboratory Medicine Online · doi:10.47429/lmo.2025.15.3.247 · Cited by 1
Wang, J. S., Battey, C. J., Trettin, K., Patel, R., Srinivasan, A. P., Saikumar, J., Kushnoor, D., Habermeyer, B. F., Ganesh, S., Xu, N., et al. (2026) · Clinical Chemistry · doi:10.1093/clinchem/hvag005 · Cited by 1
Non-invasive prenatal diagnosis of beta-thalassemia disease using digital PCR
Tangwerapornpong, C., Traisrisilp, K., Charoenkwan, P., Tongprasert, F., Phusua, A., & Fanhchaksai, K. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1771405 · Cited by 1
Emerging biomarkers and diagnostic tools for the early prediction of adverse prenatal outcomes
Soler, M., Parke, B., Kim, S. H., Terzidou, V., & Ladame, S. (2026) · npj Women s Health · doi:10.1038/s44294-026-00138-7 · Cited by 2
Vardanega, V., Bobrowska, A., Ruban‐Fell, B., Doorbar, J. A., Lombardo, S., Seedat, F., Daniel, Y., Hogan, A., Leeflang, M., Mann, K., et al. (2026) · Diagnostic and Prognostic Research · doi:10.1186/s41512-025-00192-w · Cited by 1
Vardanega, V., Bobrowska, A., Ruban‐Fell, B., Doorbar, J. A., Lombardo, S., Seedat, F., Hogan, A., Leeflang, M., Mann, K., Schuh, A., et al. (2026) · Diagnostic and Prognostic Research · doi:10.1186/s41512-025-00212-9 · Cited by 2
Non-invasive prenatal test using cell free DNA
Kim, K. (2015) · Journal of Korean Medical Association · doi:10.5124/jkma.2015.58.11.995 · Cited by 1
PURLs: Aneuploidy screening: Newer noninvasive test gains traction.
Nickolich, S., Farahi, N., Jones, K., & Mounsey, A. (2016) · Europe PMC (PubMed Central) · Cited by 1
Variabilidad de las indicaciones en el diagnóstico prenatal del síndrome de Down
Fandiño‐Losada, A., Lucumí-Villegas, B., Ramírez‐Cheyne, J., Lourido, C. I.-D., & Saldarriaga, W. (2016) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262016000100004 · Cited by 1
Non-invasive prenatal testing for Down syndrome in general maternity services
Bills, V., Ford, J., Duffner, A. M., & SOOTHILL, P. W. (2016) · British Journal of Midwifery · doi:10.12968/bjom.2016.24.8.556 · Cited by 1
Taking advantage of the disruptive impact of cell-free fetal DNA screening for aneuploidy
Hyett, J. A. (2016) · Australasian Journal of Ultrasound in Medicine · doi:10.1002/ajum.12022 · Cited by 1
Genetic Testing for Rare and Undiagnosed Diseases
Morgan, T. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800685-6.00002-3 · Cited by 3
Schwaerzler, P. (2017) · SOJ Gynecology Obstetrics and Women s Health · doi:10.15226/2381-2915/3/2/00122 · Cited by 1
Wolfberg, A. (2018) · Prenatal Diagnosis · doi:10.1002/pd.5209 · Cited by 1
Kaposy, C. (2018) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190622879.013.44 · Cited by 1
Germer, U., Kagan, K., & Gembruch, U. (2018) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-0638-4737 · Cited by 1
Diagnóstico prenatal de anomalías cromosómicas
Alegre, G., Anderlini, C., Sadir, M. V., Stehli, C., & Cuestas, E. (2019) · Methodo Investigación Aplicada a las Ciencias Biológicas · doi:10.22529/me.2019.4(4)07 · Cited by 1
La biopsie liquide : alternative ou complément à la biopsie tissulaire ?
Debré, P., Ardaillou, R., & Galibert, F. (2020) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2019.10.024 · Cited by 1
Rodríguez, R. C., Rodríguez, G. B., Rosa, C. S., López, M. Á. C., Muñoz, S. D., & León‐Justel, A. (2020) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2019-0020 · Cited by 1
Conveying Information About Screening and Diagnosis
Hewison, J., Bryant, L. D., & Fisher, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-7020-6956-7.00017-8 · Cited by 1
Prenatal Screening of Aneuploidies
Routhu, M., & Koneru, S. S. V. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96757 · Cited by 1
Fetal fraction of free-DNA: clinical-diagnostic parallels
Kudryavtseva, E. V., Kovalev, V. V., & Dektyarev, A. A. (2021) · Ural Medical Journal · doi:10.52420/2071-5943-2021-20-1-30-35 · Cited by 1
Бурка, О. А., Cherevashko, V. S., Martynova, D. A., Ishchenko, G. I., Максиян, О. И., & Knyhnytska, S. O. (2021) · Reproductive Endocrinology · doi:10.18370/2309-4117.2021.60.21-30 · Cited by 3
Genomic Pathology: Training for New Technology
Haspel, R. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-96830-8_8 · Cited by 1
Copel, J. A., Kohari, K. S., & Merriam, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816561-4.00012-0 · Cited by 1
Qi, Z., & Yu, J. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.971087 · Cited by 1
Saleh, L., Parker, G., Stevenson, M., & Miller, F. A. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09245-6 · Cited by 2
Roberts, A. W., Maisenbacher, M. K., Parmar, S., Wilkinson, J., Poll, S. R., Faulkner, N. E., & Prakash, S. K. (2023) · American Journal of Perinatology · doi:10.1055/a-2126-7476 · Cited by 1
Salisbury, A., Winston, H., Johnson, A., Pearce, A. M., Howard, K., & Norris, S. (2025) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13935 · Cited by 1
Su, J., Hansen, B. E., Ma, Z., & Peppelenbosch, M. P. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2025.107986 · Cited by 1
Quels sont l’objectif réel et la portée du dépistage des aneuploïdies ?
Quibel, T., & Rozenberg, P. (2018) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2017.12.011 · Cited by 3
Rummer, A., Sieben, W., Mosch, C. G., Assall, O., & Sauerland, S. (2019) · Medizinische Genetik · doi:10.1007/s11825-019-00251-w · Cited by 3
Noninvasive prenatal screening in twin pregnancies
Leonard, S. P., & Martin, K. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820047-6.00015-1 · Cited by 1
Suzumori, N., Takeda, E., Ebara, T., Kumagai, K., Sawada, Y., & Sugiura‐Ogasawara, M. (2020) · PubMed Central · Cited by 1
A Novel Graphic‐Aided Algorithm (gNIPT) Improves the Accuracy of Noninvasive Prenatal Testing
Zhu, Q., Wang, J., Xu, X., Zhou, S., Liao, Z., Zhang, J., Kong, L., Liang, B., & Cheng, X. (2020) · BioMed Research International · doi:10.1155/2020/4712657 · Cited by 1
PRENATAL DIAGNOSTICS IN THE I TRIMESTER OF PREGNANCY: THE CURRENT STATE OF THE PROBLEM
Kuzmina, T. E., Владимировна, Т. Е., Игнатко, И. В., & Lebedev, V. А. (2019) · V F Snegirev Archives of Obstetrics and Gynecology · doi:10.18821/2313-8726-2019-6-4-178-184 · Cited by 2
Kudryavtseva, E. V., Ekaterinburg, R. F., Kovalev, V. V., Baranov, I. I., Kanivets, I. V., OOO Genomed; Moscow, R. F., Киевская, Ю. К., OOO Genomed; Moscow, R. F., & Korostelev, S. A. (2020) · Doctor Ru · doi:10.31550/1727-2378-2020-19-8-49-54 · Cited by 1
Melcer, Y., Svirsky, R., Dvash, S., Pekar‐Zlotin, M., Meiri, H., & Maymon, R. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.02.013 · Cited by 1
Min, Y. K., & Park, K. (2021) · Medicina · doi:10.3390/medicina57060543 · Cited by 1
Prenatal Screening for Neural Tube Defects and Aneuploidy
Best, R. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815236-2.00011-4 · Cited by 1
Cheng, E. Y. (2018) · Avery's Diseases of the Newborn · doi:10.1016/b978-0-323-40139-5.00018-8 · Cited by 1
Choe, S., Kim, K., Seol, H., Lee, J. Y., Kim, M., Kim, M. H., Kwon, J. Y., Hwang, H. S., Park, C., Na, S., et al. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e326 · Cited by 1
Outcomes of 8 Years of Noninvasive Prenatal Testing at Nippon Medical School Hospital
Kawabata, I., Sahara, T., Hiraoka, S., Yonezawa, M., Miyake, H., Suzuki, S., & Yamada, T. (2022) · Journal of Nippon Medical School · doi:10.1272/jnms.jnms.2022_89-512 · Cited by 1
Helping providers interpret cell-free fetal DNA testing
Macones, G. A. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.05.042 · Cited by 1
Noninvasive Prenatal Screening and Diagnosis Using Cell‐free Fetal DNA
Hill, M. K., & Chitty, L. S. (2015) · Wiley eBooks · doi:10.1002/9781118981559.ch11 · Cited by 1
Agudo, O., & Fernanda, L. (2015) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 1
Noninvasive prenatal screening and diagnosis: from bench to clinic
Mersy, E. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20161207em · Cited by 1
The promise of non-invasive prenatal testing needs to be monitored scientifically
Lonardo, F., & Scarano, G. (2015) · BMJ · doi:10.1136/bmj.h2518 · Cited by 1
Carlsson, Y., Strömbäck, P., & Lundgren, I. (2021) · Research Square · doi:10.21203/rs.3.rs-134178/v1 · Cited by 1
Minor, L. B., & Rees, M. J. (2020) · Wiley eBooks · doi:10.1002/9781119672715.notes
The Inclusion of Race in Prenatal Screening Algorithms
Norton, M. E., & RISCH, N. J. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvae073 · Cited by 1
Self-citationGu, Y., Zheng, H., Wang, P., Liu, Y., Guo, X., Wei, Y., Yang, Z., Cheng, S., Chen, Y., Hu, L., et al. (2025) · medRxiv · doi:10.1101/2025.03.14.25323926 · Cited by 1
Comments on Editorial: Has Noninvasive Prenatal Testing (NIPT) Come of Age?
Singh, C., & Kaul, A. (2015) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-015-0758-x
Genomic Pathology: Training for New Technology
Haspel, R. L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0727-4_7
Breimer, L. H., & Nilsson, T. (2015) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2015.1057763
Advancing Horizons in Fetal Medicine
Verma, I. C. (2015) · Journal of Fetal Medicine · doi:10.1007/s40556-015-0045-z
Digital Karyotyping with Whole Genomic Sequencing for Complex Congenital Disorder
Chen, R., Li, S., Liu, G., Yuan, Y., Liu, J., Liu, T., Wu, R., Sun, Q., Ren, X., Yi, X., et al. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.06.009
Test de paternité prénatal non invasif : existe-t-il des applications en médecine légale ?
Hugodot, C., Peyron, P., & Baccino, É. (2016) · La Revue de Médecine Légale · doi:10.1016/j.medleg.2016.01.003
Prenatale diagnostiek anno 2015
Blaumeiser, B., & Jacquemyn, Y. (2016) · Bijblijven · doi:10.1007/s12414-016-0114-9
Wird das Ersttrimesterscreening noch gebraucht?
Wisser, J. (2015) · gynäkologie + geburtshilfe · doi:10.1007/s15013-015-0788-6
Análisis de ADN libre fetal para la evaluación no invasiva de trisomía (1)
Titiro, C. M., & Jorge Carvajal, C. (2016) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262016000100012
Update Ersttrimesterscreening – was ist neu in 2015?
Verlohren, S. (2015) · Frauenheilkunde up2date · doi:10.1055/s-0033-1358169
PROFESSEURS DES UNIVERSITES - PRATICIENS HOSPITALIERS
Fréger, P., Guerbet, M., Veber, B., Joly, P., & Marret, S. (2015) · Cited by 1
Nichtinvasive pränatale Tests: Überblick über die Grundlagen und den Einsatz der Methoden
Kozlowski, P. (2016) · Der Gynäkologe · doi:10.1007/s00129-016-3889-y
High-Throughput Next Generation Sequencing: Applications in Reproductive Diagnosis and Research
Parasar, P. (2016) · Gynecology and Obstetrics Research - Open Journal · doi:10.17140/goroj-3-131
Fetale DNA-Analyse aus mütterlichem Blut: Medizinischer Fortschritt oder ethische Falle?
Friebe-Hoffmann, U., & Látó, K. (2016) · Der Gynäkologe · doi:10.1007/s00129-016-3967-1
Ethical and Social Implications of Current Prenatal Genetic Testing
柘植, あ. (2016) · Journal of Mammalian Ova Research · doi:10.1274/jmor.33.109
Not-so-free testing for cell-free DNA.
Huang, D., Lundgard, K., & Kolber, M. R. (2016) · PubMed Central
Quelles stratégies pour le dépistage et le diagnostic prénatal en France ?
Vialard, F., & Quarello, E. (2017) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2017.01.017
Noninvasive prenatal test for detection of genetic diseases using next-generation sequencing
Silva, C. M. A. D. C. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2017.tde-17102017-164404
Non-invasive Prenatal Testing: A Unique Approach with Single Nucleotide Polymorphism
Dhamankar, R., Valenti, E., & Hedriana, H. L. (2018) · Journal of Fetal Medicine · doi:10.1007/s40556-018-0167-1
Profile of women choosing the Harmony® Prenatal Test
Bevilacqua, E., Resta, S., Carlin, A., Kang, X., Sanchez, T. C., de Marchin, J., & Jani, J. C. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1489242
Sacco, A., & Pandya, P. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814189-2.00004-9
Cell-Free DNA Results in Low Risk Pregnancy Screenings for Aneuploidies
Dehghani, A. M. (2018) · Austin Journal of Obstetrics and Gynecology · doi:10.26420/austinjobstetgynecol.2018.1122
Boo, H., Kim, S. Y., Seong, E. S., Kim, M. H., Kim, M. Y., Ryu, H. M., Han, Y. J., & Chung, J. H. (2018) · Journal of genetic medicine · doi:10.5734/jgm.2018.15.2.79
Routine antenatal care, antenatal testing and foetal therapy
Franx, A., Bekker, M. N., & Oepkes, D. (2019) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2131-5_16
Le dépistage prénatal non invasif de la trisomie 21. Étude rétrospective à propos de 8821 patientes
Belloin, C., Jacquemard, F., Bernabé‐Dupont, C., Viot, G., Lohmann, L., & Grangé, G. (2017) · Sages-Femmes · doi:10.1016/j.sagf.2017.07.002
Karge, A., Graupner, O., Abel, K., & Kuschel, B. (2019) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/a-0850-0650
Noninvasive prenatal testing: the aspects of its introduction into clinical practice
Korostin, D. O., Plakhina, D., & Belova, V. (2019) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2019.036 · Cited by 1
Неинвазивный пренатальный молекулярный скрининг: особенности внедрения в клиническую практику
Korostin, D. O., Plakhina, D., & Белова, В. А. (2019) · Вестник Российского государственного медицинского университета · doi:10.24075/vrgmu.2019.036
Cesarean Section Short- and Long-term Medical Implications
Papageorgiou, A. N. (2016) · Donald School Journal of Ultrasound in Obstetrics & Gynecology · doi:10.5005/dsjuog-10-2-201
Cell-free Fetal Deoxyribonucleic Acid Results in Low-risk Pregnancy Screenings for Aneuploidies
Shahbazian, N., Barati, M., Shojaei, K., Hoseininejad, S. S., & Dehghani, A. M. (2018) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-1600
Reproductive Autonomy: Sex Selection as a Defining Case Study
Siegal, G. (2019) · Springer eBooks · doi:10.1007/978-3-030-24864-2_10
Rodríguez, R. C., Rodríguez, G. B., Rosa, C. S., López, M. Á. C., Muñoz, S. D., & León‐Justel, A. (2020) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0011
Akhlaghdoust, M., & Chaichian, S. (2020) · فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران · doi:10.29252/iau.30.1.75
Wu, Y., Yang, L., Hu, Z., Zhang, H., Pu, D., Yan, H., Zhang, S., Jiang, H., Liu, Q., Yuan, Y., et al. (2020) · doi:10.22541/au.158872284.46524229
VII. Genome and Medical Administration System
Kamatani, N. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.2367
Clinical Outcome of Preimplantation Genetic Testing
Kuliev, A., Rechitsky, S., & Simpson, J. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-43157-0_7
Evidence for Routine Ultrasound Screening for Fetal Abnormalities in the Second and Third Trimesters
Afshar, Y., Rao, R., Martirosian, A., & Platt, L. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-7020-6956-7.00020-8
Genetic Screening Tests and Prenatal Diagnosis for Aneuploidies
Corda, V. (2020) · Donald School Journal of Ultrasound in Obstetrics & Gynecology · doi:10.5005/jp-journals-10009-1661
Noninvasive Screening for Cytogenetic Disorders (Fetal Aneuploidy Including Microdeletions)
Wou, K., & Wapner, R. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-7020-6956-7.00021-x
Self-citationBurrus, A. D., Shaw-Williams, M. M., & Thagard, A. S. (2020) · Military Medicine · doi:10.1093/milmed/usaa375
Prenatal Testing for Chromosomal Abnormalities
Norton, M. E. (2020) · Wiley eBooks · doi:10.1002/9781119635307.ch5 · Cited by 1
Self-citationNon-invasive prenatal testing: what an obstetrician needs to know
Mangla, M. (2020) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20205281
Metadata
- Authors
- Norton, M. E., Jacobsson, B., Swamy, G. K., Laurent, L. C., Ranzini, A. C., Brar, H., Tomlinson, M. W., Pereira, L., Spitz, J. L., Hollemon, D., Cuckle, H., Musci, T. J., & Wapner, R. J.
- Affiliations
- Saint Peter's University Hospital (US)
- Sahlgrenska University Hospital (SE)
- Duke University (US)
- University of California San Diego (US)
- Oregon Health & Science University (US)
- Perinatal Quality Foundation (US)
- Columbia University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-04-23
- Volume
- 372
- Issue
- 17
- Pages
- 1589-1597
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139926668
- Cited by
- 817
- References
- 32
- Citations by year
- 2026: 33 · 2025: 39 · 2024: 50 · 2023: 59 · 2022: 61 · 2021: 86 · 2020: 72 · 2019: 74 · 2018: 73 · 2017: 86 · 2016: 107 · 2015: 75
- FWCI
- 113.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Västra Götalandsregionen
- Thomas Jefferson University
- University of California, San Diego
- University of California, San Francisco
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Obstetrics and Gynecology › Maternal and Perinatal Health Interventions
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Keywords
- cell-free DNA, prenatal aneuploidy screening, Down syndrome, trisomy 18, trisomy 13, first-trimester screening, nuchal translucency, biochemical analytes, diagnostic accuracy, false positive rate, positive predictive value, non-invasive prenatal testing, maternal age
- MeSH terms
- Adolescent, Adult, Chromosome Aberrations, DNA, Down Syndrome, False Positive Reactions, Female, Fetus, Humans, Middle Aged, Pregnancy, Pregnancy Trimester, First, Prenatal Diagnosis, Prospective Studies, Sensitivity and Specificity, Single-Blind Method, Area Under Curve, Nuchal Translucency Measurement, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.